News - Page 10 of 10

September 15, 2025

Trialbee and BMS Session “From Click to Clinic” at DPHARM to Showcase How the Honey Platform™ Reinvents the Last Mile of Patient Recruitment for Trial Finder Websites

Trialbee will also discuss the benefits of technology-driven recruitment with Indiana Clinical Trials Center at the Partnerships with Sites...

April 1, 2025

Trialbee Screens One Million Patients on the Honey Platform™ to Drive Awareness of and Participation in Global Clinical Trials

Leading Patient Recruitment Platform (PRP) connects patients from 198 countries (65% from outside of the United States) with clinical research...

February 4, 2025

Trialbee Unveils Sponsor-Specific Registry within Honey Platform™ at SCOPE Summit to Keep Engaged Patients Ready to Enroll Across Entire Pipeline

The industry’s premier Patient Recruitment Platform (PRP) continues to increase value across sponsor organizations with enhanced engagement and streamlined...

January 30, 2025

Trialbee Reflects on a Year of Growth, Innovation, and Partnership to Drive Global Patient Recruitment in 2024

Technology-driven strategy, globally scaled delivery, patient access partnerships, and top pharma focus have made Trialbee the fastest growing platform...

January 22, 2025

Trialbee to Collaborate with Clinical Research Industry Leaders Transforming Global Patient Recruitment at SCOPE Summit 2025

Sanofi session on program-level recruitment, exciting new solutions, and hands-on Honey Platform demonstrations highlight an exciting kickoff in the...

January 9, 2025

Trialbee Becomes Only Global Recruitment Provider to Use TrialHub Data for Patient-Aligned Feasibility and Precise Funnel Projections for Clinical Trials

Collaboration provides country-specific standard of care data, disease-specific prevalence, and industry benchmarking to create a more positive patient journey...

December 17, 2024

Trialbee Partners with Inspire to Expand Clinical Research Access for 3 Million Patient Lives

Omnichannel Collaboration Improves Patient Recruitment Across 3,500 Indications with a Primary Focus on Oncology, Rare Disease, and CNS Malmo,...

Our News